Search
Subscribe for $1
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 36 of 37
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By
Jen Wieczner
November 19, 2015
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By
Alan Murray
November 19, 2015
Tech
VW’s New Horror And Facebook 3Q–5 Things To Know Today
By
Laura Lorenzetti
and
Geoffrey Smith
November 4, 2015
Finance
Pfizer-Allergan could be a super inversion deal
By
Stephen Gandel
October 29, 2015
Features
Gunboat diplomacy and Apple earnings — 5 things to know today
By
Tom Huddleston Jr.
October 27, 2015
Features
Apple’s earnings, baseball, and a Fed meeting — 5 things to know this week
By
Tom Huddleston Jr.
October 25, 2015
Health
CVS/Caremark will no longer cover these drugs, including Viagra
By
Chris Matthews
August 7, 2015
Finance
Ireland’s Horizon Pharma launches hostile, $3 billion bid for U.S. rival
By
Tom Huddleston Jr.
July 7, 2015
Commentary
Why America’s patent system is not killing innovation
By
David J. Kappos
May 8, 2015
Features
McDonald’s hikes pay, and Europe targets Apple, Google — 5 things to know today
By
John Kell
April 2, 2015
Finance
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever
By
Jen Wieczner
February 6, 2015
Commentary
U.S. corporate tax reform: why Obama’s good ideas don’t add up
By
Robert Pozen
February 5, 2015
Finance
Pfizer to acquire Hospira in a deal worth about $15 billion
By
Fortune Editors
February 5, 2015
Features
In speed mode, FDA approves Pfizer’s big new drug early
By
Jen Wieczner
February 4, 2015
Finance
Zoetis shares spike on reported Ackman stake purchase
By
Tom Huddleston Jr.
November 11, 2014
Most Popular
C-Suite
OpenAI’s Sam Altman says his highly disciplined daily routine has ‘fallen to crap’—and now unwinds on weekends at a...
By
Jacqueline Munis
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
By
Tristan Bove
Travel & Leisure
How Japan replaced France as the country young Americans obsessively romanticize—they’re longing for civility they...
By
Nick Lichtenberg